september 5, 2024

Clinical trial shows Zepbound and Mounjaro improve sleep apnea symptoms

Medical News Today
According to a clinical trial recently published in The New England Journal of Medicine, tirzepatide — the main ingredient found in type 2 diabetes medication, Mounjaro and weight loss treatment Zepbound — as a potential drug therapy for obstructive sleep apnea. The trial found that this specific drug therapy helps reduce symptom severity by almost two-thirds in adults with obesity and obstructive sleep apnea.